Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
23.72
USD
|
+0.38%
|
|
-1.54%
|
-14.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,162
|
1,037
|
1,113
|
1,083
|
1,610
|
1,373
|
-
|
-
|
Enterprise Value (EV)
1 |
1,754
|
1,710
|
1,830
|
1,938
|
2,386
|
2,147
|
2,148
|
2,145
|
P/E ratio
|
13.6
x
|
57.1
x
|
8.31
x
|
10.3
x
|
16
x
|
12.9
x
|
10.5
x
|
-
|
Yield
|
4.15%
|
1.17%
|
0.11%
|
0.45%
|
-
|
0.38%
|
0.42%
|
0.45%
|
Capitalization / Revenue
|
0.79
x
|
0.91
x
|
0.72
x
|
0.53
x
|
0.85
x
|
0.69
x
|
0.65
x
|
0.6
x
|
EV / Revenue
|
1.19
x
|
1.51
x
|
1.18
x
|
0.95
x
|
1.26
x
|
1.08
x
|
1.02
x
|
0.94
x
|
EV / EBITDA
|
6.56
x
|
8.55
x
|
6.83
x
|
6.21
x
|
7.18
x
|
6.19
x
|
5.64
x
|
5.29
x
|
EV / FCF
|
23.2
x
|
-87
x
|
-26.3
x
|
-12.8
x
|
13.8
x
|
45.8
x
|
44.7
x
|
36.4
x
|
FCF Yield
|
4.31%
|
-1.15%
|
-3.8%
|
-7.84%
|
7.25%
|
2.18%
|
2.23%
|
2.75%
|
Price to Book
|
6.25
x
|
5.73
x
|
3.48
x
|
2.35
x
|
3.36
x
|
2.49
x
|
2.12
x
|
1.89
x
|
Nbr of stocks (in thousands)
|
60,212
|
60,487
|
60,633
|
60,816
|
58,044
|
57,899
|
-
|
-
|
Reference price
2 |
19.30
|
17.14
|
18.36
|
17.81
|
27.73
|
23.72
|
23.72
|
23.72
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,476
|
1,136
|
1,547
|
2,031
|
1,894
|
1,980
|
2,108
|
2,276
|
EBITDA
1 |
267.3
|
200
|
268
|
312.3
|
332.3
|
346.9
|
380.6
|
405.8
|
EBIT
1 |
170.6
|
103.5
|
163.9
|
206.6
|
219.3
|
230.3
|
259.1
|
287.7
|
Operating Margin
|
11.56%
|
9.11%
|
10.6%
|
10.17%
|
11.58%
|
11.63%
|
12.29%
|
12.64%
|
Earnings before Tax (EBT)
1 |
119.6
|
25.8
|
185.7
|
157.2
|
163.3
|
156.6
|
191.3
|
-
|
Net income
1 |
86.92
|
18.16
|
134.7
|
106.2
|
103.5
|
109.2
|
134.3
|
-
|
Net margin
|
5.89%
|
1.6%
|
8.71%
|
5.23%
|
5.46%
|
5.52%
|
6.37%
|
-
|
EPS
2 |
1.420
|
0.3000
|
2.210
|
1.730
|
1.730
|
1.840
|
2.260
|
-
|
Free Cash Flow
1 |
75.66
|
-19.66
|
-69.5
|
-152
|
173.1
|
46.87
|
48
|
59
|
FCF margin
|
5.12%
|
-1.73%
|
-4.49%
|
-7.48%
|
9.14%
|
2.37%
|
2.28%
|
2.59%
|
FCF Conversion (EBITDA)
|
28.3%
|
-
|
-
|
-
|
52.09%
|
13.51%
|
12.61%
|
14.54%
|
FCF Conversion (Net income)
|
87.04%
|
-
|
-
|
-
|
167.25%
|
42.92%
|
35.74%
|
-
|
Dividend per Share
2 |
0.8000
|
0.2000
|
0.0207
|
0.0800
|
-
|
0.0894
|
0.0991
|
0.1065
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
393.1
|
392.7
|
484.5
|
541.2
|
543.1
|
462.1
|
500.7
|
458.8
|
466.2
|
468.2
|
506.4
|
476.6
|
503.1
|
502.1
|
542.7
|
EBITDA
1 |
66.42
|
52.3
|
83.2
|
83.4
|
80.5
|
65.2
|
101.1
|
87
|
77.3
|
66.6
|
80.03
|
87.38
|
92.55
|
86.79
|
94.31
|
EBIT
1 |
42.61
|
22.8
|
55.9
|
56
|
55.3
|
39.4
|
75.4
|
59.8
|
49.4
|
34.4
|
54.75
|
56.21
|
62.06
|
55.39
|
65.05
|
Operating Margin
|
10.84%
|
5.81%
|
11.54%
|
10.35%
|
10.18%
|
8.53%
|
15.06%
|
13.03%
|
10.6%
|
7.35%
|
10.81%
|
11.79%
|
12.34%
|
11.03%
|
11.99%
|
Earnings before Tax (EBT)
1 |
27.62
|
4.1
|
46.2
|
-
|
43.4
|
25.2
|
60.5
|
47.7
|
35
|
20.1
|
31
|
41.6
|
48.2
|
35.8
|
46.4
|
Net income
1 |
21.01
|
1.1
|
32.5
|
-
|
31.8
|
12.2
|
42.3
|
30.1
|
26.2
|
4.9
|
21.7
|
29
|
33.6
|
25
|
32.6
|
Net margin
|
5.35%
|
0.28%
|
6.71%
|
-
|
5.86%
|
2.64%
|
8.45%
|
6.56%
|
5.62%
|
1.05%
|
4.28%
|
6.08%
|
6.68%
|
4.98%
|
6.01%
|
EPS
2 |
0.3500
|
0.0100
|
0.5300
|
-
|
0.5200
|
0.2000
|
0.7000
|
0.5100
|
0.4400
|
0.0800
|
0.3700
|
0.4900
|
0.5700
|
0.4200
|
0.5500
|
Dividend per Share
2 |
-
|
-
|
0.0207
|
0.0200
|
0.0200
|
0.0200
|
0.0200
|
0.0200
|
-
|
-
|
0.0223
|
0.0223
|
0.0223
|
0.0223
|
0.0245
|
Announcement Date
|
11/4/21
|
2/17/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/16/23
|
5/4/23
|
8/9/23
|
11/2/23
|
2/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
592
|
674
|
717
|
855
|
777
|
773
|
774
|
772
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.213
x
|
3.367
x
|
2.676
x
|
2.738
x
|
2.338
x
|
2.23
x
|
2.035
x
|
1.902
x
|
Free Cash Flow
1 |
75.7
|
-19.7
|
-69.5
|
-152
|
173
|
46.9
|
48
|
59
|
ROE (net income / shareholders' equity)
|
65.1%
|
34.1%
|
42%
|
27.3%
|
24.6%
|
24.9%
|
24.7%
|
24.2%
|
ROA (Net income/ Total Assets)
|
8.87%
|
4.73%
|
8.92%
|
6.03%
|
6.2%
|
6.72%
|
7.07%
|
7.4%
|
Assets
1 |
979.7
|
383.8
|
1,510
|
1,760
|
1,671
|
1,625
|
1,899
|
-
|
Book Value Per Share
2 |
3.090
|
2.990
|
5.270
|
7.580
|
8.260
|
9.530
|
11.20
|
12.60
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
156
|
145
|
215
|
233
|
173
|
197
|
185
|
163
|
Capex / Sales
|
10.56%
|
12.75%
|
13.88%
|
11.46%
|
9.12%
|
9.93%
|
8.78%
|
7.14%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
23.72
USD Average target price
29.5
USD Spread / Average Target +24.37% Consensus |
1st Jan change
|
Capi.
|
---|
| -14.46% | 1.37B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|